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Theprospect of biomaterial hypersensitivity developing in response to joint implantmaterials was first presentedmore than 30 years
ago. Many studies have established probable causation between first-generation metal-on-metal hip implants and hypersensitivity
reactions. In a limited patient population, implant failure may ultimately be related to metal hypersensitivity. The examination
of hypersensitivity reactions in current-generation metal-on-metal knee implants is comparatively limited. The purpose of this
study is to summarize all available literature regarding biomaterial hypersensitivity after total knee arthroplasty, elucidate overall
trends about this topic in the current literature, and provide a foundation for clinical approach considerations when biomaterial
hypersensitivity is suspected.
1. Introduction
Support for the theory of joint implant loosening caused by
hypersensitivity reactions to metallic implant components
was first presented in themid-1970s [1, 2]. Studieswere under-
taken in response to clinical evidence of hypersensitivity
reactions in patients after hip arthroplasty with metal-on-
metal implants. Over the decades, this topic was examined in
many publications. In a 2012 review of all available literature,
Cousen and Gawkrodger established that first-generation
metal-on-metal implants could cause sensitization of patients
to the implant metals [3]. They also reported an association
between metal sensitization and implant failure but did
not establish a causal relationship [3]. A new generation
of metal-on-metal implants is now available to surgeons.
The widespread use of these new metal-on-metal implants,
particularly in knee arthroplasty where their use is novel,
raises questions regarding risks and benefits compared with
more established implant options.
The theory that metal sensitivity and cutaneous allergic
dermatitis develop in patients following implantation of
metallic orthopaedic devices is supported by clinical and
temporal evidence [4]. Reports also suggest that hypersen-
sitivity to implant metals occurs in a considerable number of
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patients, although the prevalence of this phenomenon is not
known [4, 5]. In a prospective study, the incidence of sen-
sitization to metals in orthopaedic implants, as determined
by patch testing, increased by 6.5% following hip and knee
arthroplasty [6]. Similarly, in a review of hip arthroplasty,
the rate of sensitivity to nickel, cobalt, or chromium was
25% in patients with well-functioning implants; this is more
than twice the rate found in the general population [7]. In
patients with a failed or failing hip prosthesis, the rate of
metal sensitivity rises dramatically to 60%, six times that
of the general population [7]. One study examined rates of
metal sensitization in patients who had undergone total knee
arthroplasty (TKA) and found a sensitization rate of 20% in
the control group with no implant, 48.1% in the group with
the stable implant, and 59.6% in the group with an unstable
implant group [8]. Mihalko et al. performed an analysis
of available prospective and retrospective studies regarding
hypersensitivity reactions after total joint arthroplasty; the
findings of this analysis are provided in Table 1 [6, 9, 10] and
Table 2 [1, 2, 11–18].The available evidence indicates a correla-
tion betweenmetallic orthopaedic implants, the development
of metal hypersensitivity, and implant loosening.
2. Results
2.1. Implant Composition and Wear. Orthopaedic implants
can be made of a variety of metallic, plastic, and/or ceramic
elements.Themetal components of knee prostheses are most
commonly stainless steel, followed by cobalt-chromium-
molybdenum (CoCrMo) alloys, nickel, titanium, Vitallium
(Austenal Company), beryllium, vanadium, and tantalum
[4, 25].
In a knee with an implant, metallic surfaces are freely
exposed to synovial fluid. Contact with biologic fluid results
in metal corrosion [3, 6, 26–31]. Cadosch et al. reported
evidence of growth and differentiation of human osteoclast
precursor cells occurring directly on surgical stainless steel,
titanium, and aluminum [30, 31].Themature osteoclasts then
directly corroded themetal surfaces and released ions into the
joint space [30, 31]. Freemetal-ion compoundsmay then bind
to endogenous proteins and form metal-protein complexes
[4, 25]. These metal-protein complexes may subsequently
initiate an immune reaction. Caicedo et al. provided evidence
that the macrophage inflammasome pathway is activated
by implant debris [28]. CoCrMo alloy debris has been
shown to induce macrophage activation, stimulate secretion
of interleukin-1 beta (IL-1𝛽), tumor necrosis factor 𝛼, IL-
6, and IL-8, and upregulate nuclear factor-𝜅𝛽 (NF-𝜅𝛽) and
downstream inflammatory cytokines [25]. Direct corrosion
of metallic surfaces by osteoclasts similarly results in ion-
induced secretion of proinflammatory cytokines [30, 31].
Although these inflammatory reactions are generally acute,
implant debris in the periprosthetic region may in some
instances result in a chronic inflammatory response [6].
2.2. Hypersensitivity Pathology. Exposure to metal ions can
occur in a number of ways. Routine metal exposure in
humans occurs through skin contact with jewelry, cell
phones, clothing fasteners, and leather and through occu-
pational exposure, dental filings, and medical implants [32].
Individuals are further exposed to trace metals through
smoking and in cosmetics, food, and drinking water [33–
35]. Nickel is the metal that most often leads to a hyper-
sensitivity reaction; studies place the prevalence of nickel
sensitivity in the general population between 8 and 25% [36–
39].
Sensitization to metal is known to occur independently
of the mechanism of exposure [4]. As previously mentioned,
metal-ion exposure produces an adaptive immune response
wherein macrophage activation leads to development of a
delayed-type hypersensitivity reaction [4, 5, 7, 26, 40, 41].
In arthroplasty patients with a metal allergy, studies have
shown elevated levels of interferon gamma and IL-6 [40,
41]. Similarly, in patients with nickel allergy, complicated
joint implants were associated with substantially elevated
levels of IL-17 when compared to uncomplicated implants
[42]. These studies provide further evidence of delayed-
type hypersensitivity reactions in response to implanted
metal. Additionally, periprosthetic immune responses to
metal have been shown to display characteristics of type I
hypersensitivity reactions [40]. There is increasing support
that metal hypersensitivity can be caused by orthopaedic
arthroplasty components. Thyssen et al. presented a list of
objective criteria which, when present in a patient, support
a causative association between implant-released metal ions
and metal hypersensitivity-induced allergic dermatitis, pain,
and implant failure [43].
2.3. Aseptic Knee Implant Loosening. Implant wear debris
is known to be an initiating event for aseptic implant
loosening [44]. A significant number of failed knee implants
display perivascular lymphocytic infiltration indicative of an
adaptive immune response; however, the question remains if
this finding truly suggests a causal relationship betweenmetal
hypersensitivity and implant failure [45]. Several studies have
indicated potential pathomechanisms for aseptic implant
loosening secondary to hypersensitivity.The commonmech-
anism is the secretion of proinflammatory cytokines induced
by metal ions; these lead to the formation of osteolytic
lesions in the bone surrounding metallic implants [30].
The NALP3 inflammasome within macrophages has been
shown to be a critical instigator and mediator of orthopaedic
implant-induced osteolysis [46]. The osteolytic mechanism
that responds to implant debris likely involves the receptor
activator of NF-𝜅𝛽 (RANK) and the receptor activator of
NF-𝜅𝛽 ligand (RANKL) pathway, as well as osteoprotegerin
and IL-18 [47]. Titanium has been shown to directly increase
the expression of RANKL, macrophage colony stimulating
factor, andTNF-𝛼 [27]. Titanium ion-induced expression and
secretion of CCL17 and CCL22, as well as upregulation of
the CCR4 receptor, result in osteoclast precursor recruitment
to the periprosthetic region, whereas the previously induced
cytokines promote osteoclast differentiation and activation
[27]. Chronic periprosthetic inflammation and the induction
of macrophage-mediated aseptic osteolysis may ultimately
result in implant loosening and failure [6].
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Table 1: Hypersensitivity reactions after total joint arthroplasty reported in prospective studies.
Prospective study title Publication Author Results
Sensitivity to implant materials in
patients undergoing total
hip-replacement
J Biomed Mater Res Granchi et al. [19]
Patch test unable to differentiate stable
versus unstable implants, equivalent
implant lifespan in metal patch +; 10 yr
survival for metal patch + 44% versus
patch − 47%; poor survival for cement
patch +
Allergy to components of total hip
arthroplasty before and after surgery
Ital J Orthop
Traumatol Cancilleri et al. [20]
10/66 THA patch + (1/12 w/aseptic
loosening patch +), 2/41 preop. patch +;
hypersensitivity may play role in
loosening, but likely small
Metal sensitivity in patients with
metal-to-plastic total hip arthroplasties Acta Orthop Scand Carlsson et al. [11]
9/112 patch + preop., 12/112 patch +
postop.; all complications except 1/246
explained by reasons other than
hypersensitivity
Allergy in hip arthroplasty Contact Dermatitis Waterman and Schrik[21]
13/85 patch + preop. (13 metal), 25/85
patch + postop. (23 metal, 2 cement), 0/10
loose THA patch +; no evidence to
suggest loosening because of
hypersensitivity
The development of metal
hypersensitivity in patients with
metal-to-plastic hip arthroplasties
Contact Dermatitis Nater et al. [22]
0/66 patch + preop., 4/66 patch + MOP
conversion postop.; no clinical sequelae,
no need to test
Metal sensitivity in patients with
orthopedic implants: a prospective study Contact Dermatitis Frigerio et al. [6]
16/72 (22%) preop. + patch or LTT, (19/72
(29%) postop. (5 conversions of 72 total));
if preop. history insufficient, recommend
for screening tests
Metal sensitivity before and after total hip
arthroplasty J Bone Joint Surg Am Deutman et al. [23]
10/173 patch + preop., 4/66 converted
patch + postop. MOP; no conclusion
Metal sensitivity in patients undergoing
hip-replacement J Bone Joint Surg Br
Rooker and
Wilkinson [10]
6/69 patch + preop. MOP, only 1/54 patch
+ postop.; patch + may be effect not
cause, no need to screen in MOP
The effect of patch testing on surgical
practices and outcomes in orthopedic
patients with metal implants
Arch Dermatol Mesinkovska et al. [9]
31 with history of hypersensitivity preop.,
21 patch +, all did well with
“allergen-free” implants; 41 suspected of
hypersensitivity w/TJA, 10 patch +, 6/10
had resolution of symptoms with allergen
free implant; recommend patch testing in
those with history
Screening for symptomatic metal
sensitivity: a prospective study of 92
patients undergoing total knee
arthroplasty
Biomaterials Niki et al. [24]
24/92 TKA were mLST+ preop., 5/24
developed eczema, Cr + in eczema
patients but not in others; screening
indicated
Prospective study summary
Preop. patch/LTT +: 56/618 (9.1%),
postop.: 73/521 (14.1%)
Conversion of patch/LTT preop. to
postop.: 56/618 (9.1%) preop. versus
73/521 (14.0%) postop.
3. Patients
3.1. Published Case Studies. The majority of information
regarding hypersensitivity reactions followingTKA is derived
from a limited number of case studies. The authors reviewed
all available published reports of metallic knee implant-
associated hypersensitivity reactions; details of the individual
case studies are outlined in Table 3 and summarized in the
following paragraph [12, 48–55].
In the 28 reported cases of metal hypersensitivity reac-
tions after TKA, 23 of the patients were female [12, 48–55].
Seven patients had a history of metal hypersensitivity before
the arthroplasty [52–54]. The orthopaedic implants associ-
ated with reactions were composed of various combinations
ofmetals, including cobalt, chromium,molybdenum, copper,
nickel, titanium, aluminum, and vanadium [12, 48–55]. Most
patients presented with varying degrees of periprosthetic
irritation, although one patient presented with systemic
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Table 2: Hypersensitivity reactions after total joint arthroplasty in retrospective studies.
Retrospective study title Publication Author Results
Contact allergy to metals and bone
cement components in patients with
intolerance of arthroplasty
Dtsch Med
Wochenschr Eben et al. [15]
In cemented TJA: 22/66 symptomatic pts.
patch +, asymptomatic patch + 3/26
Allergy to metals as a cause of
orthopaedic implant failure
Int J Occup Med
Environ Health Kręcisz et al. [16]
14 poor implants, 8 patch + (7 ni, 6 cr), 3




J Bone Joint Surg Am Park et al. [17] 8/9MoM w/osteolysis patch + to Co,2/9w/o osteolysis patch +; retrospective
Sensitivity to metal as a possible cause of
sterile loosening after cobalt-chromium
total hip-replacement arthroplasty
J Bone Joint Surg Am Brown et al. [18] 0/20 loose MoM patch + (1977)
Metal sensitivity as a cause of bone
necrosis and loosening of the hip
prosthesis in total joint replacement
J Bone Joint Surg Br Evans et al. [2] 9/14w/loose joints patch +, 0/24w/stablejoints
Incidence of metal sensitivity in patients
with total joint replacements Br Med J Elves et al. [1]
15/23 failed TJA patch +, 4/27 stable patch
+, 8/13 w/derm rxn were patch +
Dermatitis on the knee following knee
replacement: a minority of cases contact
allergy to chromate, cobalt, or nickel but
a causal association is unproven
Contact Dermatitis Verma et al. [12] 7 of 15 patients w/cutaneous symptomspatch +
Metal sensitivity in patients with
metal-to-plastic total hip arthroplasties Acta Orthop Scand Carlsson et al. [11]
13/134MOP patch + postop.; unsure if
hypersensitivity caused by THA, but, in
pts. w/Hx of allergy, proceed w/caution
Retrospective evaluation of patch testing
before or after metal device implantation Arch Dermatol Reed et al. [13]
5/22 with history of hypersensitivity
preop. patch +, 0/22 referred for patch
test postop. were patch +
Lymphocyte responses in patients with
total hip arthroplasty J Orthop Res Hallab et al. [14]
More + LTT and cytokine release in
THA, and esp. in loose THA
Retrospective study summary
Revised: 33/138 (23.9%) patch +, 44/303
(14.5%) patch + in stable TJA
Failed/loose: 113/261 (43.3%) patch +,
32/146 (21.9%) patch + in TJA
Total: 146/399 (36.6%) patch +, 76/449
(16.9%) patch −
10/16 (62.5%) revised TJAs LTT +
dermatitis.Therewas a report of decreased range ofmotion in
three patients; in one of these patients, arthroscopy demon-
strated a lymphoplasmacellular fibrinous tissue consistent
with a delayed-type hypersensitivity reaction [48, 50, 55].
Skin patch testing was performed in all but 1 of the 28
patients, with 18 of the patients having positive results [12,
48, 49, 51–55]. Lymphocyte transformation testing (LTT) was
performed in six patients, including the one patient who was
not testedwith a skin patch [50, 54]. Five patients had positive
lymphocyte transformation tests. Aseptic implant failure was
observed in two patients [53, 54]. Both patients experienced
implant failure with the initial replacement and with the
first revision procedure. After the second revision procedure
using hypoallergenic implants, the dermatologic symptoms
resolved and the implants remained stable. It is important to
note that there have been two published case studies in which
both patients had a history of metal hypersensitivity but did
not develop any adverse hypersensitivity reactions following
TKA even though the implants contained components to
which the patients were allergic [13, 57].
3.2. Risk Factors. The risk of becoming sensitized to metal
varies largely depending on an individual’s exposure. Sev-
eral risk factors for developing metal hypersensitivity have
been identified, including age, gender, and occupation. With
increasing age, there is a decreased risk of developing nickel
hypersensitivity [36, 37, 39]. This may be attributed to
decreased lifetime exposure of older individuals to metallic
costume jewelry [36]. Exposure to costume jewelry (particu-
larly earrings) may also account for the sex discrepancy that
is observed in patients with metal hypersensitivity [36, 58].
In general, women are at an increased risk for developing
hypersensitivity to several metals [8]. Epidemiologic studies
place the rate of nickel sensitization in women between 17%
and 32%, whereas the sensitization rate inmen is significantly
lower—between 3 and 10% [36, 37, 58]. The rate of cobalt
sensitization is 11.2% in women and 8.4% in men [58]. The
literature identifies only one metal to which men are more
sensitized than women. The rate of chromium sensitization
in men is 10.1% whereas in women it is 7.9% [58]. Interest-
ingly, these differences correspond to metal exposures that











































































































































































































































































































































































































































































































































































































































































































































































6 BioMed Research International
occur in traditionally sex-specific occupations. Chromium
hypersensitivity is associated with concrete exposure in the
construction industry, leatherwork and tanning, and occupa-
tions involved in cleaning [32, 36, 58]. Sensitization to cobalt
is also associated with occupations involved in cleaning
and leatherwork, as well as hairdressing and professions in
the textile industry [58]. Nickel sensitization is associated
with occupations in healthcare, agriculture, mechanics, and
metalwork [58].
A history of metal allergy in patients may also be a
significant risk factor that should be taken into consideration
before TKA. Granchi et al. reported the implant failure rate
that was four times greater in patients with a self-reported
history of preoperative metal allergy compared with patients
who did not have a metal allergy [8].
3.3. Presentation. As with all pathological processes, hyper-
sensitivity reactions to metallic knee implants can present
several ways. Metal hypersensitivity may result in localized
or systemic allergic dermatitis, loss of joint function, implant
failure, and patient dissatisfaction [32]. Hypersensitivity reac-
tions after TKA are most commonly present in the first few
postoperative months as pruritic, erythematous, eczematous,
edematous, sometimes painful, and sometimes exudative
lesions in the periprosthetic region [12, 48–55]. In patients
with a TKA implant containing metal, the clinician should
consider metal hypersensitivity when dermatologic allergic
symptoms are reported. Furthermore, metal hypersensitivity
should be considered in such patients when they present with
arthralgia, when periprosthetic radiolucent lines appear, or
when aseptic implant loosening is observed [59].
4. Screening
4.1. Patient History. The patient history plays an invaluable
role in making a diagnosis in every field of medicine. When
diagnosing metal hypersensitivity, patient-reported history
of a metal allergy should not be ignored. In a study of 22
patients with a self-reported history ofmetal hypersensitivity,
skin patch test results were positive in 19 patients [13].
A similar study found positive gold standard skin patch
test results in 68% of the patients with a history of metal
allergy [9]. It should be considered, however, that the patient
history and gold standard skin patch test results do not
necessarily correlate, particularly in patients with a history
that is negative for metal hypersensitivity [60]. Frigerio et al.
reported that patient history taking is appreciably less reliable
than gold standard testing in determiningmetal sensitization;
the sensitivity of patient history is 85.5% and the specificity is
83.5% [6].
4.2. Patch Testing. Cutaneous patch testing is the gold
standard for in vivo evaluation of delayed hypersensitivity
reactions [5]. As previously discussed, metal hypersensitivity
to orthopaedic implants displays distinct characteristics of
delayed-type hypersensitivity. Many physicians believe that
the patch testmethod is an acceptable approach for evaluating
hypersensitivity to orthopaedic joint implant components
[8].
In the general population, there has been a significant
increase in the number of positive patch test results over the
past four decades; this increase is most likely attributable to a
substantial rise in the number of metals tested [61]. Despite
this increase in the general population, patients who have
undergone TKA remain significantly more likely to have a
positive patch test [8, 61]. The rate of positive patch test
results to metals is even greater in patients with metal-on-
metal implants and in those with a failed prosthesis [61].
This correlates with the finding that positive patch tests are
associated with shorter implant lifespans [19].
There are several advantages to evaluating metal hyper-
sensitivity with patch tests following total knee arthroplasty.
In a published report of 21 patients with positive patch tests
to metals, none experienced hypersensitivity reactions after
TKA with hypoallergenic implants [9]. These findings can
be viewed as support for the argument that preoperative
patch testing potentially prevents significant morbidity [5].
Practical advantages of cutaneous patch testing include ease
of performance, rapidity of results, the scope of evaluation,
and widespread availability [19, 43]. As with all ideal testing
methods, the risk to the patient in patch testing is generally
quite low [5].
Without disputing the numerous advantages of patch
testing, questions remain regarding the propriety of patch
testing in evaluating implant-induced hypersensitivity reac-
tions. Some investigators cite the differences in antigen-
presenting cells in superficial and deep tissues as a cause for
doubt; this doubt leads to questions regarding the validity of
cutaneous test results as they relate to periprosthetic tissue [7,
8, 14, 25]. Other investigators have noted that, despite a strong
correlation, no causal relationship has been definitively estab-
lished between dermal reactions and implant failure [50].
Analyses have determined that patch testing results, although
valuable in patients with suspected hypersensitivity, had no
predictive value for complications when performed prior to
arthroplasty [8, 61]. These arguments have contributed to the
reluctance of orthopaedic surgeons to use cutaneous patch
testing in routine orthopaedic practice [3, 25, 62].
Although primarily theoretical, a potential disadvantage
of patch testing is that the process of in vivo patch testing
could potentially induce sensitization in a previously non-
sensitized patient [25]. If this occurred in a patient who had
previously undergone arthroplasty, it could place the patient
at risk of significant morbidity secondary to an iatrogenically
induced hypersensitivity.
Patch testing remains the gold standard for evaluation
of delayed-type hypersensitivity. Its preoperative use should
strongly be considered in patients with a history of metal
allergies and its postoperative use in patients presenting with
either suspected metal hypersensitivity or implant failure in
the absence of infection [5, 61].
4.3. Lymphocyte Transformation Testing. Lymphocytes trans-
formation testing (LTT) can be used as an alternativemethod
to determine metal sensitivity in a patient. This in vitro test
measures the proliferation of lymphocytes from a patient’s
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peripheral blood in the presence and absence of a potential
allergen [5]. It has been suggested for use when patch testing
provides questionable results [5, 19].
LTT has several important advantages compared to cuta-
neous patch testing. In determining a patient’s reactivity
to metal, LTT offers greater sensitivity than patch testing
[40]. Because of the nature of the LTT construct, highly
quantifiable and reproducible measures of sensitivity are
available; no such objective results exist for patch testing [43,
63]. Unlike patch testing, LTT cannot induce sensitization
because it is performed in vitro [63]. The greatest risk to
a patient with LTT is venipuncture. Most encouragingly, a
prospective study using LTT prior to arthroplasty indicated
that it may be effective as a preoperative screening tool for
metal hypersensitivity [24].
LTT remains largely impractical for routine clinical use.
The availability of laboratories equipped to perform this test
is limited; such facilities are primarily restricted to university
settings [5, 43]. Because few allergens are tested, LTT is
much more restricted in breadth of evaluation compared to
patch testing [5]. Although LTT is known to have a greater
sensitivity compared to patch testing, the precise sensitivity
and specificity of LTT have not yet been established [25, 40].
4.4. Other Screening Options. Beecker et al. reported on a
case study of a patient with a known history of metal hyper-
sensitivity and established positive patch test reactions to
nickel and cobalt [52]. The patient underwent subcutaneous
embedding of cobalt and titanium implants [52]. At 6 weeks,
no reaction to the implantedmetals was noted; however, after
the patient underwent TKA of the left knee, periprosthetic
allergic contact dermatitis developed [52]. One year later,
the patient underwent total knee arthroplasty of the right
knee [52]. Periprosthetic hypersensitivity reactions again
developed [52]. No established guidelines exist regarding the
depth or the duration of subcutaneous metal implantation as
a screening test for hypersensitivity. This patient’s outcome
suggests the poor sensitivity of thismethod for at least the first
6 weeks of subcutaneous metal implantation. This approach
is not recommended.
4.5. Timing. Standard screening of all patients for metal
hypersensitivity prior to total knee arthroplasty is not appro-
priate [43]. In addition to generating unnecessary expense,
a large portion of the general population tests positive
for nickel allergy despite the absence of hypersensitivity
symptoms [36–39]. Therefore, preoperative testing is only
indicated in patients with a history of either metal allergy
or previous aseptic orthopaedic implant failure [9, 43]. Some
additional guidelines for preoperative patch testing exist.
Schalock et al. recommend using a baseline series based
on the patient’s place of residence [5]. Various national and
international dermatologic organizations have established
appropriate baselines. A history of hypersensitivity to metals
that are not included in the baseline serieswarrants expansion
of the testing parameters [5].
Postoperative testing for metal sensitization is appropri-
ate in a select group of patients. Such testing should be con-
sidered if a patient presents with recent onset periprosthetic
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allergic contact dermatitis or arthralgia andwhen radiolucent
lines appear on radiographs or implant loosening is observed
[5, 59]. Infectious etiologies of these symptoms should be
ruled out first.
5. Prevention and Management
5.1. Case Study Follow-Up. In the case studies previously
discussed, patients withmetal hypersensitivity weremanaged
with a variety of approaches. The details of individual case
studies are outlined in Table 3. The dermatologic symptoms
of 15 patients were resolved completely with the use of top-
ical corticosteroid [12]. The bilateral intermittent cutaneous
reactions of one patient were managed with topical treatment
over an 8-year coursewith topical treatment [52]. Ten patients
were treated with surgical revision utilizing hypoallergenic
prostheses; the revision implants included four titanium-
based implants, two zirconium-nickel coated implants, one
zirconium-ceramic alloy implant, one titanium and ceramic
implant, one cobalt and ceramic alloy coated implant, and one
ceramic implant [48, 50, 51, 53–55]. One case study did not
mention the treatment approach or patient outcome [49].
5.2. Approach Considerations. Several diagnostic algorithms
have been suggested for orthopaedic patients with suspected
metal hypersensitivity [5, 61]. Comprehensive diagnosis and
treatment algorithm are presented in Figures 1 and 2, respec-
tively. Postoperative intervention should followpositive patch
test results onlywhenpatients are symptomatic or the implant
demonstrates clear evidence of failure [5, 9]. Consideration
8 BioMed Research International
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also should be given to nonmetal allergic reactions after TKA.
Benzoyl peroxide found in bone cement may cause delayed
hypersensitivity reactions [5, 64, 65].
There are many options when considering implants for
patients who are sensitive to metal. The ideal prosthesis
does not contain metals to which the patient has been
sensitized [5]. Because titanium sensitivity is rare, it has been
suggested that titanium implants be used in all TKA patients.
These implants, however, are inappropriate for most patients
because they are typically unnecessary and are substantially
more expensive [43]. Patients who are sensitive tometal, even
those with titanium-coated prostheses, experience greater
functional limitations and decreased quality of life compared
with their nonallergic counterparts with standard implants
[56]. The most important consideration is whether aseptic
loosening has occurred secondary to metal hypersensitivity
[66].
6. Conclusion
Currently available evidence demonstrates both incidence
and probable mechanisms for metal hypersensitivity reac-
tions after total knee arthroplasty. This is an uncommon
complication but must be recognized to ensure the health
and satisfaction of patients. Some studies acknowledge the
correlation but do not identify a causative relationship. How-
ever, based on the current evidence, the authors of this paper
believe in a likely casual association between metallic knee
implants and hypersensitivity reactions that can potentially
lead to aseptic implant failure.
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